Medical devices sold in Brazil must be manufactured by a manufacturer with a Quality Management System (QMS) that complies with the Brazilian Standards of Good Manufacturing Control (BGMP) (RDC 665/2022 and RDC 497/2021). In Brazil, Class III and Class IV manufacturers are required to obtain a BGMP certificate, which is valid for two years. ANVISA uses a risk-based approach (RDC 217/2018 and RDC..